The U.S. Food and Drug Administration (FDA) has raised doubts about Strides Pharma Sciences Ltd's quality-control practices after finding adulteration and evidence of "uncontrolled shredding of documents" at one of its plants.
from Reuters: Health News https://ift.tt/2JBW9Hs
via
IFTTT
0 comments:
Post a Comment